title: Are we ready to curtail testing for TEL/AML1 fusion? Pediatric Hematology Working Group in the Czech Republic.
authors.forename: O
authors.initials: O
authors.lastname: Hrusák
authors.forename: J
authors.initials: J
authors.lastname: Trka
authors.forename: J
authors.initials: J
authors.lastname: Zuna
authors.forename: J
authors.initials: J
authors.lastname: Bartůnková
authors.forename: J
authors.initials: J
authors.lastname: Starý
mesh_terms: D002648:Child; D002675:Child, Preschool; D050676:Core Binding Factor Alpha 2 Subunit; D006098:Granulocytes; D006801:Humans; D007519:Isoantigens / Q000032:analysis; D009363:Neoplasm Proteins / Q000032:analysis*; D015514:Oncogene Proteins, Fusion; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000378:metabolism* / Q000503:physiopathology; D011993:Recombinant Fusion Proteins / Q000032:analysis; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D050676:Core Binding Factor Alpha 2 Subunit; D007519:Isoantigens; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; D011993:Recombinant Fusion Proteins; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein